在重症监护医学的标准化解决方案 catecholamines:应用,安全和经济方面
Armin Niklas Flinspach1, André Mohr2,3, Jahn Wehrle3
1Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe-University Frankfurt, Theodor-Stern Kai 7, 60590 Frankfurt, Germany.
Journal of clinical medicine
|June 19, 2024
概括
准备施用的 катехоламин溶液,特别是诺阿基尼林,提高了患者的安全性,并在重症监护室 (ICU) 提供了经济效益. 内部药房生产是优化重症监护医学的可行策略.
科学领域:
- 关键护理医学 关键护理医学
- 临床药房 临床药房
- 药物经济学 药物经济学
背景情况:
- 甲基荷胺在重症监护医疗中至关重要,需要易于获得,安全和正确缩的注射溶液.
- 在不同的医院病房中,可获得和分配最优的甲基荷胺需要进一步调查.
- 越来越多的急症护理需求和人员短缺凸显了有效药物管理的必要性.
研究的目的:
- 研究在重症监护病房 (ICU) 和中等护理病房 (IMC) 持续给药的甲醇胺的利用模式.
- 评估通过制造的准备使用的溶液来优化甲基胺可用性的潜力.
- 评估内部药房生产与床边制剂对经济和患者安全的影响.
主要方法:
- 从2019年到2022年进行了一项回顾性,单心研究.
- 数据收集集中在ICU和IMC中的所有持续注入的甲醇胺.
- 分析包括对内部药房生产与床边准备即用溶液的比较.
主要成果:
- 上腺素注射器占所有注射器的81%,表明其在病房中经常使用.
- 公司内部药房生产的甲基胺注射器证明了财务优势.
- 与床边制剂相比,公司内部药房的生产导致了患者安全的提高.
结论:
- 医院应对甲醇胺制剂进行个别经济评估.
- 公司内部生产准备好使用和准备好使用的甲醇胺溶液可以显著提高患者的安全性.
- 在经济上可行的内部制造重症监护药物为优化流程和患者护理提供了有希望的方法.
相关概念视频
Adrenergic Agonists: Therapeutic Uses
766
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
766
Adrenergic Agonists: Mixed-Action Agents
701
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
701
Adrenergic Agonists: Therapeutic Classification
767
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
767
Adrenergic Agonists: Direct-Acting Agents
1.4K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.4K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
725
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
725
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.1K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.1K


